Takeshi Azuma

5PUBLICATIONS
0CO-AUTHORS
Immunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 29, 2022
Utility of periodic medical questionnaires and examinations for immune-related adverse event screening: A prospective observational study.

Takeshi Azuma, Masato Kano, Shohei Iwata

|Jul 26, 2021
Nivolumab and Ipilimumab Combination Immunotherapy for Patients with Metastatic Collecting Duct Carcinoma.

Tetsuya Danno, Shohei Iwata, Fusako Niimi

|Dec 11, 2020
Serum soluble B7-H3 is a prognostic marker for patients with non-muscle-invasive bladder cancer.

Takeshi Azuma, Yujiro Sato, Tatsukuni Ohno

|Jul 26, 2018
Serum soluble B7-H4 is a prognostic marker for patients with non-metastatic clear cell renal cell carcinoma.

Takeshi Azuma, Yujiro Sato, Tetsukuni Ohno

|Jan 10, 2018
Comparing sequencing of abiraterone and enzalutamide in men with metastatic castration-resistant prostate cancer: A retrospective study.

Takeshi Azuma

Pageof 1

Frequent Collaborators